Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 22 of 183 for:    DCLRE1C

Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) (ARTEMIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02357147
Recruitment Status : Terminated (Due to business reasons)
First Posted : February 6, 2015
Last Update Posted : June 24, 2019
Sponsor:
Information provided by (Responsible Party):
Morphotek

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 30, 2018
Actual Study Completion Date : November 30, 2018